ClinicalTrials.Veeva

Menu

Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Diffuse Large B Cell Lymphoma

Study type

Observational

Funder types

Other

Identifiers

NCT04423549
B2020-034

Details and patient eligibility

About

The purpose of this study is to determine the predictive value of a mRNA signature and liquid biopsy in patients with Diffuse Large B cell lymphoma.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • biopsy proved Diffuse Large B cell Lymphoma
  • newly diagnosed between 2000-01 and 2015-12

Exclusion criteria

  • patients with biopsy samples unavailable

Trial design

800 participants in 2 patient groups

tested group
controlled group

Trial contacts and locations

1

Loading...

Central trial contact

Qing qing Cai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems